Zhong Nanshan: Traditional Chinese medicine should dare to accept modern medical examination

Recently, the list of "2017 comprehensive statistics ranking of China's OTC products" compiled by China OTC association was released Lianhua Qingwen capsule, which has been used in 120000 hospitals and pharmacies in the country for more than ten years since its launch, has become a regular drug for families, taking 80 million people per year, and won the second place in the list of cold and cough Lianhua Qingwen capsule contains ephedra, mint, honeysuckle, forsythia, isatis root, gypsum, rhubarb and other ingredients According to reports, Lianhua Qingwen does not antagonize a single virus with Western antiviral drugs, but plays a broad-spectrum antiviral role by clearing the plague and detoxifying, catharsis of lung heat Many scientific research institutions, such as the Chinese Academy of traditional Chinese medicine and the State Key Laboratory of respiratory diseases of Guangzhou Medical College, have proved this through pharmacological research: Lianhuaqingwen has a strong inhibition and killing effect on influenza A virus (H1N1, H3N2), influenza B virus, avian influenza virus (H5N1, H9N2), adenovirus, herpes virus, etc At the same time, Lianhuaqingwen also has the functions of antibacterial, antipyretic, analgesic, anti-inflammatory, antitussive, expectorant, enhancing immunity, etc., to prevent and treat pneumonia and bronchitis that may be caused by influenza Academician Zhong Nanshan also pointed out that in the most strict double-blind evidence-based medicine research recognized by clinicians, Lianhua Qingwen showed the therapeutic effect of effectively reducing the symptoms of influenza patients, especially the patients with high fever symptoms had better effect in the early stage of the disease According to academician Zhong Nanshan, the concept of antiviral of traditional Chinese medicine is different from that of Western medicine In 2011, Lianhua Qingwen won the second prize of national science and technology progress award In 2016, Lianhua Qingwen began to carry out phase II clinical trials in the United States, becoming the first anti influenza Chinese medicine to enter the FDA clinical research in the United States In the past ten years, Lianhuaqingwen has successively entered the guidelines for the prevention and control of influenza, avian influenza and other infectious diseases issued by the national health and Family Planning Commission and other government departments for 14 times According to academician Zhong Nanshan, more western medicine believes in traditional Chinese medicine because modern scientific research methods are more used in the research of traditional Chinese medicine in terms of methods, techniques and thinking He suggested that all traditional Chinese medicine, whether single or compound, should dare to accept the test of modern medicine like Lianhuaqingwen capsule!